Fig. 1From: How I approach weaning from venoarterial ECMOVA-ECMO weaning process. *Criteria required to initiate weaning trial: (1) Phenotype is compatible with recovery (2) End-organ function is improving (3) Pa02/Fi02 > 100 (4) Vasopressors and intropes at low levels (norepinephrine ≤ 4 μg/min, dobutamine < 5 mcg/kg/min) **Any of the following criteria constitutes failure of a weaning trial: (1) MAP falls below 65–70 mmHg or decreases by more than 10 mmHg from baseline (2) Significant increase in intracardiac filling pressures (3) Deterioration in respiratory statusBack to article page